Healthpeak Properties, Inc.
DOC- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0000765880
No open-market purchases or sales by Healthpeak Properties, Inc. insiders were filed in the last 90 days; 763 institutions reported holding it in 13F filings for Q2 2026, worth $14.2B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Healthpeak Properties, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Healthpeak Properties, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thomas John T | Director | 829,975 | Jun 2, 2026 | 3 |
| Brinker Scott M | President and CEO | 214,688 | Jun 2, 2026 | 4 |
| Johnston Shawn G | EVP and CAO | 42,260 | Jun 2, 2026 | 3 |
| Mabry Adam G | CIO | 5,097 | Jun 2, 2026 | 3 |
| Patadia Ankit B. | EVP and Treasurer | 8,953 | Jun 2, 2026 | 3 |
| Moses Kelvin O | Chief Financial Officer | 1,627 | Jun 2, 2026 | 3 |
| Bohn Scott R | CDO and Head of Lab | 7,636 | May 13, 2026 | 2 |
| Lewis Sara Grootwassink | Director | 56,488 | May 7, 2026 | 1 |
| Griffin R Kent Jr | Director | 90,195 | May 7, 2026 | 1 |
| Connor James B. | Director | 38,169 | May 7, 2026 | 1 |
| Weiss Richard A. | Director | 79,469 | May 7, 2026 | 1 |
| Cartwright Brian G. | Director | 83,490 | May 7, 2026 | 1 |
| Sandstrom Katherine M | Director | 76,669 | May 7, 2026 | 1 |
| Lias-Booker Ava | Director | 45,305 | May 7, 2026 | 1 |
| Alonso Lisa A | EVP and Chief HR Officer | 22,271 | Feb 17, 2026 | 4 |
| Porter Tracy A | EVP and General Counsel | – | Jan 30, 2026 | 1 |
| Thompson Tommy G | Director | 144,290 | May 28, 2025 | 0 |
| Shelley-Kessler Pamela | Director | 50,307 | Apr 29, 2025 | 0 |
| Miller Jeffrey H | General Counsel | 31,255 | Feb 3, 2025 | 0 |
| Klaritch Thomas | COO | 330,412 | Feb 3, 2025 | 0 |
| Scott Peter A | CFO | 164,339 | Feb 3, 2025 | 0 |
| Garvey Christine | Director | 8,193 | May 1, 2023 | 0 |
| Henry David | Director | 84,910 | May 1, 2023 | 0 |
| Herzog Thomas M | CEO | 85,348 | Feb 6, 2023 | 0 |
| McHenry Troy E. | CLO and GC | 138,258 | Oct 4, 2022 | 0 |
| Kennard Lydia H | Director | 27,826 | May 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 (view filing) | Sep 9 | 4 days | Garvey ChristineDirector | SSale | −575 | $36.20 | −$20.8K | −2.4%23.0K after | |
| Nov 22, 2021 (view filing) | Nov 19 | 3 days | Garvey ChristineDirector | SSale | −300 | $34.36 | −$10.3K | −1.3%22.7K after | |
| Nov 17, 2022 (view filing) | Nov 16 | 1 day | Garvey ChristineDirector | SSale | −1.86K | $24.77 | −$46.1K | −7.0%24.8K after | |
| Dec 28, 2022 (view filing) | Dec 27 | 1 day | Garvey ChristineDirector | SSale | −1.00K | $25.12 | −$25.1K | −4.0%23.8K after | |
| Feb 23, 2023 (view filing) | Feb 22 | 1 day | Garvey ChristineDirector | SSale | −1.20K | $25.45 | −$30.5K | −5.0%22.6K after | |
| Mar 2, 2023 (view filing) | Mar 2 | Same day | Brinker Scott MPresident and CEO | PPurchase | +16.3K | $23.63 | +$385.2K | +8.6%206.5K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Klaritch ThomasCOO | PPurchase | +1.52K | $23.21 | +$35.2K | +0.4%344.0K after | |
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | Lewis Sara GrootwassinkDirector | PPurchase | +4.00K | $21.43 | +$85.7K | New position4.00K after | |
| Mar 4, 2024 (view filing) | Mar 4 | Same day | Lewis Sara GrootwassinkDirector | PPurchase | +18.0K | $16.71 | +$300.8K | +450.0%22.0K after | |
| Apr 28, 2025 (view filing) | Apr 28 | Same day | Brinker Scott MPresident and CEO | PPurchase | +11.3K | $17.68 | +$200.4K | +6.0%201.9K after | |
| Apr 28, 2025 (view filing) | Apr 28 | Same day | Shelley-Kessler PamelaDirector | PPurchase | +2.84K | $17.62 | +$50.0K | +251.8%3.96K after | 2 lots |
| Apr 28, 2025 (view filing) | Apr 28 | Same day | Lewis Sara GrootwassinkDirector | PPurchase | +6.00K | $17.66 | +$106.0K | +200.0%9.00K after | |
| Apr 28, 2025 (view filing) | Apr 28 | Same day | Sandstrom Katherine MDirector | PPurchase | +11.3K | $17.65 | +$199.2K | +25.1%56.3K after | |
| Apr 28, 2025 (view filing) | Apr 28 | Same day | Thomas John TDirector | PPurchase | +4.20K | $17.84 | +$74.9K | +0.5%813.6K after | |
| Apr 29, 2025 (view filing) | Apr 29 | Same day | Lias-Booker AvaDirector | PPurchase | +5.00K | $17.83 | +$89.2K | +16.4%35.6K after | |
| May 12, 2025 (view filing) | May 9 | 3 days | Brinker Scott MPresident and CEO | PPurchase | +2.75K | $17.39 | +$47.8K | +1.4%204.6K after | |
| May 12, 2025 (view filing) | May 9 | 3 days | Thompson Tommy GDirector | PPurchase | +5.70K | $17.36 | +$99.0K | +4.3%138.5K after | |
| May 28, 2025 (view filing) | May 28 | Same day | Thompson Tommy GDirector | PPurchase | +5.78K | $17.27 | +$99.8K | +4.2%144.3K after | |
| Jul 29, 2025 (view filing) | Jul 28 | 1 day | Brinker Scott MPresident and CEO | PPurchase | +2.87K | $17.40 | +$50.0K | +1.4%207.5K after | |
| Jul 31, 2025 (view filing) | Jul 31 | Same day | Brinker Scott MPresident and CEO | PPurchase | +2.93K | $17.06 | +$50.0K | +1.4%210.4K after | |
| Aug 4, 2025 (view filing) | Aug 4 | Same day | Brinker Scott MPresident and CEO | PPurchase | +1.49K | $16.83 | +$25.1K | +0.7%211.9K after | |
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Thomas John TDirector | PPurchase | +1.45K | $17.06 | +$24.7K | +0.2%810.0K after | |
| May 13, 2026 (view filing) | May 12 | 1 day | Bohn Scott RCDO and Head of Lab | SSale | −11.0K | $19.45 | −$213.7K | −59.0%7.64K after |